| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |